Skip to main content
Premium Trial:

Request an Annual Quote

PGXL, Silicon Biosystems Partner on DEPArray Technology

NEW YORK (GenomeWeb News) – PGXL Technologies and Silicon Biosystems today announced a deal to make Silicon Bio's DEPArray technology available through PGXL.

As a result of the partnership, clinical researchers and pharmaceutical sponsors will be able to "obtain the level of data fidelity and resolution needed in cancer biomarker discovery and translational research," the two companies said.

The DEPArray technology is based on dielectrophoresis for isolating and manipulating cells in a suspension matrix. Silicon Bio said that it can be used to investigate the underlying causes of disease, disease progression, and the basis of drug resistance and efficacy.

Bob Proulx, president and general manager of Silicon Bio's US operations, said that there has been gathering interest in having DEPArray available on a fee-for-service basis. The company last year added a demonstration and training laboratory, "but partnering with PGXL for [contract research organization] services will add a whole new dimension to our ability to reach and impact the market … We partnered with PGXL because they bring highly complementary capabilities and expertise to the equation," he said.

The DEPArray technology and supporting technologies will be available in the summer.

Financial and other terms of the deal were not disclosed.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.